Cena s DPH / bez DPH
Hlavní stránka>BS EN 62337:2012 Commissioning of electrical, instrumentation and control systems in the process industry. Specific phases and milestones
sklademVydáno: 2013-06-30
BS EN 62337:2012 Commissioning of electrical, instrumentation and control systems in the process industry. Specific phases and milestones

BS EN 62337:2012

Commissioning of electrical, instrumentation and control systems in the process industry. Specific phases and milestones

Formát
Dostupnost
Cena a měna
Anglicky Zabezpečené PDF
K okamžitému stažení
7320 Kč
Anglicky Tisk
Skladem
7320 Kč
Označení normy:BS EN 62337:2012
Počet stran:40
Vydáno:2013-06-30
ISBN:978 0 580 81737 3
Status:Corrigendum
Popis

BS EN 62337:2012


This standard BS EN 62337:2012 Commissioning of electrical, instrumentation and control systems in the process industry. Specific phases and milestones is classified in these ICS categories:
  • 91.040.20 Buildings for commerce and industry
  • 91.010.20 Contractual aspects
  • 25.040.01 Industrial automation systems in general

This International Standard defines specific phases and milestones (see Figure 1) in the commissioning of electrical, instrumentation and control systems in the process industry. By way of example, it describes activities following the “c ompletion-of-erection” milestone o f the project and prior to the “a cceptance-of-the-plant” phase by the owner. Such activities need to be adapted for each t ype of process/plant concerned.

NOTE This standard assumes that the “acceptance -of-the-plant” milestone will occur after the performance test. If there is a reduced scope, this document should be adapted accordingly.

NOTE Construction and precommissioning activities could be overlapping.

For application in the pharmaceutical or other highly specialized industries, additional guidelines (for example, Good Automated Manufacturing Practice (GAMP)), definitions and stipulations should apply in accordance with existing standards, for example, for GMP Compliance 21 CFR (FDA) and the Standard Operating Procedure of the European Medicines Agency (SOP/INSP/2003).